BioSante Announces Positive Data on Leukemia Drug
BioSante Pharmaceuticals may be known for its sexual health products such as LibiGel, but the Illinois-based company is also developing a novel immunotherapy vaccine to treat cancer.
cancer
IMUC: Immunotherapy On Multiple Fronts
In a study of 19 patients with glioblastoma, progression-free survival increased from 6 months to 19 months.
LAMP May Light the Way to New Generation of Vaccines
LAMP (Lysosome-Associated Membrane Protein) is a gene that has been shown to enhance immune response when incorporated into a DNA vaccine.
For Advaxis, Bacteria Help More Than They Hurt
The idea of using harmful bacteria to treat disease might strike many as an odd concept.
Quintessence Biosciences’ Novel Approach to Cancer Therapy
Quintessence Biosciences is a biopharmaceutical company specializing in the development of novel protein-based therapeutics to fight cancer.
TapImmune Taps Into Cancer Defense
How do cancer cells evade the immune system, growing undetected until they’re discovered as a tumor?
Quintessence Biosciences at the 2010 OneMedForum
Laura Strong, President and COO of Quintessence Biosciences, discusses her company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
[OneMedForum] Senesco Technologies: Life and Death on a Cellular Level
“Programmed cell death” sounds a bit sinister, but it’s actually a normal and healthy process.
TapImmune, Inc. at the 2010 OneMedForum
Denis Corin, President of TapImmune, Inc., discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
[OneMedForum] Biomoda’s Platform for Early Cancer Detection
Biomoda’s CyPath diagnostic assay is based on molecular marker technology originally developed at the Los Alamos National Laboratory.